These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24964695)

  • 41. Economic evaluation and health care decision-making.
    Rutten F
    Health Policy; 1996 Jun; 36(3):215-29. PubMed ID: 10158267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
    Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic evaluation of health care technologies.
    Jönsson B
    Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():50-4. PubMed ID: 8342394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health care technology assessment: implications for modern medical practice. Part I. Understanding technology adoption and analyses.
    Pierce RG; Bozic KJ; Hall BL; Breivis J
    Am J Orthop (Belle Mead NJ); 2007 Jan; 36(1):11-4. PubMed ID: 17460869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An introduction to the methods of cost-effectiveness analysis.
    Drug Ther Bull; 2012 Jul; 50(7):81-4. PubMed ID: 22789768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cost of illness studies as a basis for decision making].
    Henke KD; Martin K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Jan; 49(1):19-27. PubMed ID: 16341605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP; Neumann PJ; Willke RJ; Basu A; Danzon PM; Doshi JA; Drummond MF; Lakdawalla DN; Pauly MV; Phelps CE; Ramsey SD; Towse A; Weinstein MC
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health economic evaluation in Japan: a case study of one aspect of health technology assessment.
    Oliver A
    Health Policy; 2003 Feb; 63(2):197-204. PubMed ID: 12543532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of health economics in the evaluation of surgery and operative technologies.
    Taylor M
    Surgery; 2017 Feb; 161(2):300-304. PubMed ID: 28096035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost analyses in assistive technology research.
    Harris F; Sprigle S
    Assist Technol; 2003; 15(1):16-27. PubMed ID: 14760978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Importance of Economic Evaluation in Health Care: An Indian Perspective.
    Dang A; Likhar N; Alok U
    Value Health Reg Issues; 2016 May; 9():78-83. PubMed ID: 27881265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What decision-makers want and what they have been getting.
    McGregor M
    Value Health; 2006; 9(3):181-5. PubMed ID: 16689712
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost-of-illness studies: concepts, scopes, and methods.
    Jo C
    Clin Mol Hepatol; 2014 Dec; 20(4):327-37. PubMed ID: 25548737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measurement of health outcomes.
    Thavorncharoensap M
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S27-32. PubMed ID: 24964696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?
    Husereau D; Culyer AJ; Neumann P; Jacobs P
    Appl Health Econ Health Policy; 2015 Jun; 13(3):273-9. PubMed ID: 25316309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The assessment of diagnostic imaging technologies: a policy perspective.
    Hailey D; McDonald I
    Health Policy; 1996 May; 36(2):185-97. PubMed ID: 10158768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health technology assessment in developing the National List of Essential Medicines in Thailand.
    Thamlikitkul V
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S3. PubMed ID: 24964692
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-cost technologies and public policy.
    Shine KI
    Int J Technol Assess Health Care; 1997; 13(4):562-71. PubMed ID: 9489249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].
    Willke RJ; Neumann PJ; Garrison LP; Ramsey SD
    Value Health; 2018 Feb; 21(2):155-160. PubMed ID: 29477393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.
    Davies L; Coyle D; Drummond M
    Soc Sci Med; 1994 Jun; 38(12):1601-7. PubMed ID: 8047917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.